Login to Your Account



Taiho, Sumitomo commit $30M each to build new Remiges VC fund

By Catherine Makino
Staff Writer

Wednesday, July 30, 2014

TOKYO – Two Japanese pharma companies are investing tens of millions into a new biotech venture fund created by Remiges Biopharma Fund LP as they look for new collaborations outside Japan.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription